C
Core Biogenesis
Biotech & Life Sciences · Strasbourg, France · Founded 2020
Core Biogenesis produces pharma-grade recombinant proteins with its plant-based bioproduction platform. Our first products are growth factors used for Cell Therapy manufacturing and Cultivated meat… MoreLess
Developer of bioproduction technologies designed to use plants as biofactories to scale the production of high-value bioproducts. The company's ultra-scalable bioproduction as a service (UBaaS) platform accelerates mass production and isolates molecules to a specific plant compartment, making extraction faster, and more scalable and it also offers proprietary gene editing and plant biotechnology to produce GF(Growth Factors) molecules used in the clean meat and cell therapy industries, which regulate the growth, division, and survival of cells, enabling clients to increase yields while driving down costs. Keywords: Pharmaceuticals and Biotechnology, Bioproduction Facility, Biotech Company, Biotechnology Processing, Cytokines Synthesis, Growth Factoring Molecules, Protein Production, Recombinant Molecule Production, Recombinant Protein Bioproduction.
Company overview
Core Biogenesis company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Strasbourg, France
- Employees
- 31
- Open positions
- None listed
- Dealroom signal
- 78.3
Valuation & funding
Core Biogenesis funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Mar 2022 | $1.2M | — | European Innovation Council | — |
| SERIES A✓Equity / VC | Mar 2022 | $11M | $44M | Blue Horizon · Blue Horizon Equity · XAnge · Entrepreneurs First | ↗ |
| SEED✓Equity / VC | Dec 2020 | $2.9M | $11M | Plug and Play · XAnge · Entrepreneurs First | — |
| SPINOUT✓Other financing | May 2020 | $0 | — | INRAE | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
Growth signals
Core Biogenesis website traffic
Latest recorded traffic for Core Biogenesis is 310 monthly website visits, down 47.5% over the last three months. Core Biogenesis's team grew 3.3% over the past year.
Comparisons
Core Biogenesis compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Core Biogenesis's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Core Biogenesis has talent and traffic
team presence
In the news
Latest news about Core Biogenesis
Recent press, funding announcements, and product moves mentioning Core Biogenesis — open to read from the original sources.
Market sentiment
What the market is saying about Core Biogenesis
An AI-synthesized read of the highest-engagement posts about Core Biogenesis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Core Biogenesis’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.